4D Molecular Therapeutics, Inc. (FDMT): SCHEDULE 13G/A filed Feb 17, 2026

Name: 4D Molecular Therapeutics, Inc. SCHEDULE 13G/A (0001388325-26-000011)
Creator: 4D Molecular Therapeutics, Inc.
Published: 2026-02-17

Form type: SCHEDULE 13G/A
Filing date: Feb 17, 2026
Accession number: 0001388325-26-000011
Filer: 4D Molecular Therapeutics, Inc. (CIK 1650648)